Avatrombopag

Red

Brand Name(s):

Indication:Thrombocytopenia (chronic liver disease needing a procedure)

Rationale:1,2

Considered:Sep-20

Review Date:Sep-25

Comments:
NICE TA626
on avatrombopag (Doptelet) for treating severe thrombocytopenia in adults with chronic liver disease needing a planned invasive procedure.
Full guidance
https://www.nice.org.uk/guidance/ta626